Elanco Animal Health Trading Overview
Elanco Animal Health Inc. (ticker: ELAN) closed the trading session on Friday, 23 November 2026 at USD 22.69 per share, reflecting a –0.66 % decline from the previous 24‑hour period. The closing time was 10:26 AM Central Europe.
| Item | Value |
|---|---|
| Current price | USD 22.69 |
| Market capitalization | USD 11.20 billion |
| Shares outstanding | 499.5 million |
| 24‑hour trading volume | USD 109.6 million |
| Month‑end change | –1.66 % |
| 200‑day simple moving average | USD 23.82 |
| 52‑week high | USD 27.98 (08/05/2026) |
| 52‑week low | USD 19.40 (05/19/2026) |
The stock has traded at a lower level compared with its 200‑day moving average and has shown a modest decline from the previous month’s closing price.
Comparative Performance of Related Stocks (Last 24 Hours)
| Company | Ticker | % Change | Current price (USD) | Market cap (USD bn) | P/E ratio |
|---|---|---|---|---|---|
| CoStar Group Inc. | CSGP | +7.75 % | 35.45 | 13.30 | 185.75 |
| CNA Financial Corp. | CNA | +2.21 % | 49.39 | 13.10 | 10.63 |
| Carlyle Group Inc. | CG | +5.18 % | 39.20 | 13.30 | 38.60 |
| Brown‑Forman Corp. | BF‑A | +7.14 % | 30.91 | 13.00 | 18.17 |
| BridgeBio Pharma | BBIO | +0.28 % | 68.12 | 13.20 | — |
All the referenced companies are listed on the New York Stock Exchange. Their recent gains are highlighted in the context of broader S&P 500 performance, with CoStar Group identified as a notable contributor to the index’s gains during the session.
Company Profile
Elanco Animal Health Inc. is a veterinary pharmaceuticals and animal health products company headquartered in Greenfield, United States. The firm focuses on the development, manufacturing, and marketing of products for companion and food animals. Elanco’s global clientele is served through its website, www.elanco.com . The company was listed on the New York Stock Exchange following its initial public offering on 20 September 2018.
